Lipoprotein(a) and Incident Venous Thromboembolism

JAMA Cardiology·September 23Open Access

Cardiac & Cardiovascular Systems Limited evidence Venous Thromboembolism Cohort Study Lipoprotein(A) Measurement

Summary

What was studied

This cohort study evaluated the association between measured lipoprotein(a) [Lp(a)] levels and the risk of incident venous thromboembolism (VTE).

Study limitations

The full text is not publicly available (embargoed until 2027-09-23), so specific results, sample size, follow-up duration, and methodological details cannot be assessed.

Caveats

No abstract with results was available, so key findings, population characteristics, and study limitations could not be verified or summarized
Prior evidence on Lp(a) and VTE is conflicting (some meta-analyses show association; at least one large study and a Mendelian randomization study do not), so conclusions from this study should be interpreted in that context once full data are accessible
The full text of this article is not publicly available (PMC embargo until 2027-09-23); all extractable information is limited to the plain-language summary and publisher page metadata — specific results, sample size, effect sizes, and methodological details are unknown

Lipoprotein(a) and Incident Venous Thromboembolism

Summary

What was studied

Study limitations

Caveats

Related Questions

Lipoprotein(a) and Incident Venous Thromboembolism

Summary

What was studied

Study limitations

Caveats

Related Questions